OxyDial

OxyDial is a medical technology company that specializes in innovative blood testing solutions aimed at enhancing patient care and advancing medical research. The company has developed a next-generation blood testing instrument that measures the Oxygen-hemoglobin Dissociation Curve and other important blood parameters, such as MetHemoglobin. This portable device is designed for speed, precision, and ease of use, requiring only a single drop of blood and offering significant improvements in accuracy and testing time compared to existing devices. OxyDial's technology supports various applications, including pharmaceutical research and development, clinical care, chronic disease management, and emergency medical services. The company also addresses needs in military applications, athletic training, animal testing, and field testing environments. In addition to the blood testing instrument, OxyDial provides a cloud platform for data analysis and management, enhancing diagnostic capabilities and research efficiency for a wide range of customers, including pharmaceutical companies, clinical researchers, and healthcare providers.

• Employees 19
• Founded 2022